TABLE 2.
In vitro MICs of levofloxacin, ciprofloxacin, and moxifloxacin for 12 M. avium subsp. hominissuis clinical isolates
| Sample ID | gyrA mutation | MIC (μg/mL) of: |
||
|---|---|---|---|---|
| Levofloxacin | Ciprofloxacin | Moxifloxacin | ||
| Koav 1 | None | <0.5 | <0.5 | <0.125 |
| Koav 2 | None | 2 | <0.5 | 0.5 |
| Koav 3 | Asp95Gly | 64 | 32 | 8 |
| Koav 11 | Asp95Tyr | 8 | 16 | 4 |
| Koav 13 | Asp95Gly | 128 | 64 | 16 |
| Koav 15 | None | 4 | 2 | 0.5 |
| Koav 16 | None | <0.5 | <0.5 | <0.125 |
| Koav 19 | None | 2 | 1 | 0.5 |
| Koav 20 | None | <0.5 | <0.5 | <0.125 |
| Koav 21 | None | 4 | 2 | 1 |
| Koav 25 | None | 4 | 2 | 1 |
| CI-A2 | Asp95Tyr | 64 | 32 | 8 |